Literature DB >> 19148135

Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria.

E J Houwerzijl1, H-W D Pol, N R Blom, J J L van der Want, J Th M de Wolf, E Vellenga.   

Abstract

Recent studies in erythroid cells have shown that autophagy is an important process for the physiological clearance of mitochondria during terminal differentiation. However, autophagy also plays an important role in removing damaged and dysfunctional mitochondria. Defective mitochondria and impaired erythroid maturation are important characteristics of low-risk myelodysplasia. In this study we therefore questioned whether the autophagic clearance of mitochondria might be altered in erythroblasts from patients with refractory anemia (RA, n=3) and RA with ringed sideroblasts (RARS, n=6). Ultrastructurally, abnormal and iron-laden mitochondria were abundant, especially in RARS patients. A large proportion (52+/-16%) of immature and mature myelodysplastic syndrome (MDS) erythroblasts contained cytoplasmic vacuoles, partly double membraned and positive for lysosomal marker LAMP-2 and mitochondrial markers, findings compatible with autophagic removal of dysfunctional mitochondria. In healthy controls only mature erythroblasts comprised these vacuoles (12+/-3%). These findings were confirmed morphometrically showing an increased vacuolar surface in MDS erythroblasts compared to controls (P<0.0001). In summary, these data indicate that MDS erythroblasts show features of enhanced autophagy at an earlier stage of erythroid differentiation than in normal controls. The enhanced autophagy might be a cell protective mechanism to remove defective iron-laden mitochondria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148135     DOI: 10.1038/leu.2008.389

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  20 in total

1.  Enhanced mitophagy in Sertoli cells of ethanol-treated rats: morphological evidence and clinical relevance.

Authors:  Nabil Eid; Yuko Ito; Yoshinori Otsuki
Journal:  J Mol Histol       Date:  2011-11-11       Impact factor: 2.611

Review 2.  Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Alexander Scarth Watson; Monika Mortensen; Anna Katharina Simon
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

Review 3.  Mitophagy in hematopoietic stem cells: the case for exploration.

Authors:  Aashish Joshi; Mondira Kundu
Journal:  Autophagy       Date:  2013-10-11       Impact factor: 16.016

4.  Global transcriptome analyses of human and murine terminal erythroid differentiation.

Authors:  Xiuli An; Vincent P Schulz; Jie Li; Kunlu Wu; Jing Liu; Fumin Xue; Jingping Hu; Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2014-03-17       Impact factor: 22.113

Review 5.  Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes.

Authors:  Alexia Eliades; Shinobu Matsuura; Katya Ravid
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

6.  Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice.

Authors:  XiuJie Li-Harms; Sandra Milasta; John Lynch; Christopher Wright; Aashish Joshi; Rekha Iyengar; Geoffrey Neale; Xi Wang; Yong-Dong Wang; Tomas A Prolla; James E Thompson; Joseph T Opferman; Douglas R Green; John Schuetz; Mondira Kundu
Journal:  Blood       Date:  2014-11-19       Impact factor: 22.113

7.  Lentiviral vector-mediate ATG3 overexpression inhibits growth and promotes apoptosis of human SKM-1 cells.

Authors:  Lin Wang; Jin Song; Jing Zhang; Chen Zhu; Yan Ma; Xiaoping Xu
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

8.  The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance.

Authors:  Monika Mortensen; Elizabeth J Soilleux; Gordana Djordjevic; Rebecca Tripp; Michael Lutteropp; Elham Sadighi-Akha; Amanda J Stranks; Julie Glanville; Samantha Knight; Sten-Eirik W Jacobsen; Kamil R Kranc; Anna Katharina Simon
Journal:  J Exp Med       Date:  2011-02-21       Impact factor: 14.307

Review 9.  Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Authors:  Lisa Pleyer; Peter Valent; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-06-27       Impact factor: 5.923

Review 10.  Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype.

Authors:  David A Sallman; Thomas Cluzeau; Ashley A Basiorka; Alan List
Journal:  Front Oncol       Date:  2016-06-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.